|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Decroisette C, Galerneau LM, Hominal S and
Chouaid C: Epidemiology, management and cost of bone metastases
from lung cancer. Rev Mal Respir. 30:309–315. 2013.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Romeo MS, Sokolova IA, Morrison LE, Zeng
C, Barón AE, Hirsch FR, Miller YE, Franklin WA and Varella-Garcia
M: Chromosomal abnormalities in non-small cell lung carcinomas and
in bronchial epithelia of high-risk smokers detected by
multi-target interphase fluorescence in situ hybridization. J Mol
Diagn. 5:103–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Massion PP and Carbone DP: The molecular
basis of lung cancer: Molecular abnormalities and therapeutic
implications. Respir Res. 4:122003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masuda A and Takahashi T: Chromosome
instability in human lung cancers: Possible underlying mechanisms
and potential consequences in the pathogenesis. Oncogene.
21:6884–6897. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Glisovic T, Bachorik JL, Yong J and
Dreyfuss G: RNA-binding proteins and post-transcriptional gene
regulation. FEBS Lett. 582:1977–1986. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sutherland LC, Rintala-Maki ND, White RD
and Morin CD: RNA binding motif (RBM) proteins: A novel family of
apoptosis modulators? J Cell Biochem. 94:5–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JY, Chan EK, Peng XX and Tan EM: A
novel cytoplasmic protein with RNA-binding motifs is an autoantigen
in human hepatocellular carcinoma. J Exp Med. 189:1101–1110. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xin H, Deng K and Fu M:
Post-transcriptional gene regulation by RNA-binding proteins in
vascular endothelial dysfunction. Sci China Life Sci. 57:836–844.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gerstberger S, Hafner M, Ascano M and
Tuschl T: Evolutionary conservation and expression of human
RNA-binding proteins and their role in human genetic disease. Adv
Exp Med Biol. 825:1–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim MY, Hur J and Jeong S: Emerging roles
of RNA and RNA-binding protein network in cancer cells. BMB Rep.
42:125–130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lukong KE, Chang KW, Khandjian EW and
Richard S: RNA-binding proteins in human genetic disease. Trends
Genet. 24:416–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Musunuru K: Cell-specific RNA-binding
proteins in human disease. Trends Cardiovasc Med. 13:188–195. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumar R, Vadlamudi RK and Adam L:
Apoptosis in mammary gland and cancer. Endocr Relat Cancer.
7:257–269. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Motyl T, Gajkowska B, Zarzynska J,
Gajewska M and Lamparska-Przybysz M: Apoptosis and autophagy in
mammary gland remodeling and breast cancer chemotherapy. J Physiol
Pharmacol. 57 Suppl 7:S17–S32. 2006.
|
|
17
|
Kechavarzi B and Janga SC: Dissecting the
expression landscape of RNA-binding proteins in human cancers.
Genome Biol. 15:R142014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shao C, Zhao L, Wang K, Xu W, Zhang J and
Yang B: The tumor suppressor gene RBM5 inhibits lung adenocarcinoma
cell growth and induces apoptosis. World J Surg Oncol. 10:1602012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Martinez-Arribas F, Agudo D, Pollán M,
Gómez-Esquer F, Díaz-Gil G, Lucas R and Schneider J: Positive
correlation between the expression of X-chromosome RBM genes (RBMX,
RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer.
J Cell Biochem. 97:1275–1282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tzifi F, Economopoulou C, Gourgiotis D,
Ardavanis A, Papageorgiou S and Scorilas A: The role of BCL2 family
of apoptosis regulator proteins in acute and chronic leukemias. Adv
Hematol. 2012:5243082012.PubMed/NCBI
|
|
21
|
Alberg AJ and Nonemaker J: Who is at high
risk for lung cancer? Population-level and individual-level
perspectives. Semin Respir Crit Care Med. 29:223–232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buyukcelik A, Yalcin B and Utkan G:
Multidisciplinary management of lung cancer. N Engl J Med.
350:2008–2010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 350:379–392. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martin-Garabato E, Martinez-Arribas F,
Pollán M, Lucas AR, Sánchez J and Schneider J: The small variant of
the apoptosis-associated X-chromosome RBM10 gene is co-expressed
with caspase-3 in breast cancer. Cancer Genomics Proteomics.
5:169–173. 2008.PubMed/NCBI
|
|
25
|
Wang K, Bacon ML, Tessier JJ, Rintala-Maki
ND, Tang V and Sutherland LC: RBM10 modulates apoptosis and
influences TNF-α gene expression. J Cell Death. 5:1–19.
2012.PubMed/NCBI
|
|
26
|
Delbridge AR and Strasser A: The BCL-2
protein family, BH3-mimetics and cancer therapy. Cell Death Differ.
22:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ziegler A, Luedke GH, Fabbro D, Altmann
KH, Stahel RA and Zangemeister-Wittke U: Induction of apoptosis in
small-cell lung cancer cells by an antisense oligodeoxynucleotide
targeting the Bcl-2 coding sequence. J Natl Cancer Inst.
89:1027–1036. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Glantz LA, Gilmore JH, Lieberman JA and
Jarskog LF: Apoptotic mechanisms and the synaptic pathology of
schizophrenia. Schizophr Res. 81:47–63. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pang H, Flinn R, Patsialou A, Wyckoff J,
Roussos ET, Wu H, Pozzuto M, Goswami S, Condeelis JS, Bresnick AR,
et al: Differential enhancement of breast cancer cell motility and
metastasis by helical and kinase domain mutations of class IA
phosphoinositide 3-kinase. Cancer Res. 69:8868–8876. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Camacho EM, Mesa-Pereira B, Medina C,
Flores A and Santero E: Engineering Salmonella as
intracellular factory for effective killing of tumour cells. Sci
Rep. 6:305912016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Fu GF, Fan YR, Liu WH, Liu XJ, Wang
JJ and Xu GX: Bifidobacterium adolescentis as a delivery system of
endostatin for cancer gene therapy: Selective inhibitor of
angiogenesis and hypoxic tumor growth. Cancer Gene Ther.
10:105–111. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Low KB, Ittensohn M, Le T, Platt J, Sodi
S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, et al:
Lipid A mutant Salmonella with suppressed virulence and
TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol.
17:37–41. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Theys J, Landuyt W, Nuyts S, Van Mellaert
L, van Oosterom A, Lambin P and Anné J: Specific targeting of
cytosine deaminase to solid tumors by engineered Clostridium
acetobutylicum. Cancer Gene Ther. 8:294–297. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lerman MI and Minna JD: The 630-kb lung
cancer homozygous deletion region on human chromosome 3p21.3:
Identification and evaluation of the resident candidate tumor
suppressor genes. The international lung cancer chromosome 3p21.3
tumor suppressor gene consortium. Cancer Res. 60:6116–6133.
2000.PubMed/NCBI
|
|
35
|
Swanton E, Savory P, Cosulich S, Clarke P
and Woodman P: Bcl-2 regulates a caspase-3/caspase-2 apoptotic
cascade in cytosolic extracts. Oncogene. 18:1781–1787. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu GS and Ding Z: Caspase 9 is required
for p53-dependent apoptosis and chemosensitivity in a human ovarian
cancer cell line. Oncogene. 21:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
|
